Walgreens Boots Alliance Inc (NASDAQ:WBA) has received an average rating of “Buy” from the twenty-four ratings firms that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $84.29.
A number of equities analysts have weighed in on the stock. Barclays assumed coverage on shares of Walgreens Boots Alliance in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price target for the company. BidaskClub upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Bank of America started coverage on shares of Walgreens Boots Alliance in a research report on Tuesday, February 27th. They issued a “neutral” rating and a $76.00 price target for the company. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Tuesday, March 6th. Finally, Needham & Company LLC restated a “buy” rating and set a $88.00 target price (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th.
In other Walgreens Boots Alliance news, insider Stefano Pessina purchased 98,858 shares of the firm’s stock in a transaction that occurred on Monday, January 15th. The shares were bought at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 14.80% of the stock is owned by corporate insiders.
Walgreens Boots Alliance (NASDAQ WBA) traded down $0.83 on Friday, hitting $69.03. 887,122 shares of the company’s stock were exchanged, compared to its average volume of 5,600,449. The company has a market capitalization of $69,495.43, a price-to-earnings ratio of 19.30, a P/E/G ratio of 1.16 and a beta of 1.21. Walgreens Boots Alliance has a fifty-two week low of $63.82 and a fifty-two week high of $87.79. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.10 earnings per share. equities research analysts expect that Walgreens Boots Alliance will post 5.79 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Monday, March 12th. Investors of record on Thursday, February 15th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.32%. The ex-dividend date of this dividend was Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is 44.20%.
TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance Inc (WBA) Receives $84.29 Average Target Price from Analysts” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://sportsperspectives.com/2018/03/14/walgreens-boots-alliance-inc-wba-receives-84-29-average-target-price-from-analysts.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.